We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Participants at the Second Global Forum on Pharmaceutical Anticounterfeiting
in Paris demand increased cooperation at all levels and a framework convention
to fight counterfeiting of medicines.
U.S.-based Pfizer has emerged as the biggest pharma patent applicant in India
as the Kolkata-based Patents Office opened the mailbox of patent pleas for pharma
and agrochem inventions for 1995-2005.
HBM BioVentures (Cayman) Ltd. announced that it has purchased an additional
3,964,615 common shares of Aspreva Pharmaceuticals Corporation (Aspreva), or
approximately 12 percent of such shares outstanding based on the 32,948,378
common shares outstanding on March 3, 2005 in connection with the initial public
offering of Aspreva, which closed on March 9, 2005.
Ozgene Pty Ltd (Perth, Australia) announced that
it has reached a final milestone in one it's drug target validation projects
for NV Organon (Netherlands).
Sources within Indonesia's drug industry have claimed that the country's
drug sector faces substantial changes in the wake of the ASEAN Free Trade Agreement
(AFTA), scheduled to be introduced by 2009.
A U.S. organization running a clinical trial in Nigeria to test whether the
anti-HIV drug Viread is effective in preventing HIV infections in high-risk
populations has called off the study because of the failure of local researchers
to meet international scientific standards, London's Financial Times reports.